Jiong P. Yu
79 Qingchun Rd
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome-Acute Kidney Injury: A Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Mesenchymal stem cell-derived extracellular vesicles attenuate periductal fibrosis by inhibiting Th17 differentiation in human liver multilineage organoids and Mdr2-/- mice.
Journal: Journal of nanobiotechnology
Published: January 10, 2025
Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: October 30, 2024
Impact of Donor CMV-Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
Journal: Journal of medical virology
Published: August 19, 2024
Human placenta mesenchymal stromal cells alleviate intestinal inflammation and repair intestinal barrier function by activating AMPK-FXR pathway.
Journal: Communications biology
Published: August 07, 2024
aCCI-HBV-ACLF: A Novel Predictive Model for Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Journal: Alimentary pharmacology & therapeutics
Published: June 11, 2024
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening.
Journal: Biomolecules
Published: May 02, 2024
Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis.
Journal: Stem cell research & therapy
Published: April 29, 2024
ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 12, 2024
Plasma metabolome analysis for predicting antiviral treatment efficacy in chronic hepatitis B: diagnostic biomarkers and therapeutic insights.
Journal: Frontiers in immunology
Published: April 09, 2024
Corrigendum to "A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation" [Pharmacol. Res. 194 (2023) 106851].
Journal: Pharmacological research
Published: March 09, 2024
Last Updated: 09/26/2026